These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 347892)

  • 61. Amantadine may stimulate dopamine and noradrenaline receptors.
    Papeschi R
    Neuropharmacology; 1974 Jan; 13(1):77-83. PubMed ID: 4522901
    [No Abstract]   [Full Text] [Related]  

  • 62. Effect of mild hypoxia on catecholamine metabolism in different areas of the rat brain.
    Zaleska M
    Bull Acad Pol Sci Biol; 1979; 27(3):237-44. PubMed ID: 497878
    [No Abstract]   [Full Text] [Related]  

  • 63. Catecholamine and octopamine concentrations in brains of patients with Reye syndrome.
    Lloyd KG; Davidson L; Price K; McClung HJ; Gall DG
    Neurology; 1977 Oct; 27(10):985-8. PubMed ID: 333308
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis of isomeric thienobenzothiazines and their effect on dopamine metabolism in rat brain.
    Grol CJ; Rollema H; Dijkstra D; Westerink BH
    J Med Chem; 1980 Mar; 23(3):322-4. PubMed ID: 6102606
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Arginine8-vasopressin affects catecholamine metabolism in specific brain nuclei.
    Tanaka M; de Kloet ER; de Wied D; Versteeg DH
    Life Sci; 1977 Jun; 20(11):1799-808. PubMed ID: 875620
    [No Abstract]   [Full Text] [Related]  

  • 66. Ventromedial hypothalamic lesions and brain catecholamines.
    Glick SD; Greenstein S; Waters DH
    Pharmacol Biochem Behav; 1973; 1(5):591-2. PubMed ID: 4524529
    [No Abstract]   [Full Text] [Related]  

  • 67. Effects of (+/-)-10-hydroxy-N-n-propylnoraporphine on catecholamine turnover in the rat brain.
    Neumeyer JL; Uretsky NJ; Charest RR
    J Pharm Pharmacol; 1977 Mar; 29(3):179-81. PubMed ID: 15086
    [No Abstract]   [Full Text] [Related]  

  • 68. Deficient dopamine metabolism in the celiac ganglion of spontaneously hypertensive rats.
    Lütold BE; Karoum F; Neff NH
    Circ Res; 1979 Apr; 44(4):467-71. PubMed ID: 428044
    [No Abstract]   [Full Text] [Related]  

  • 69. Changes induced by DMet2-pro5-enkephalinamide in plasma insulin response to glucose in the rat.
    Ferri S; Spampinato S; Costa G
    Biochem Pharmacol; 1979 Nov; 28(22):3346-7. PubMed ID: 526342
    [No Abstract]   [Full Text] [Related]  

  • 70. Catalepsy and hyperkinesis induced by the chronic injection of a tetrapeptide into the neostriatum.
    Yakimovskii AF
    Neurosci Behav Physiol; 1992; 22(3):224-9. PubMed ID: 1508334
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Catalepsy induced by alpha-methyl-p-tyrosine and d-amphetamine: the rôle of catecholamine metabolism.
    Sayers AC; Handley SL
    Psychopharmacologia; 1974 Feb; 34(4):325-34. PubMed ID: 4855871
    [No Abstract]   [Full Text] [Related]  

  • 72. Are there opiate receptors in the invertebrates?
    Osborne NN; Neuhoff V
    J Pharm Pharmacol; 1979 Jul; 31(7):481. PubMed ID: 38324
    [No Abstract]   [Full Text] [Related]  

  • 73. Comparative study on the activity of chlorpromazine and 7-hydroxychlorpromazine in the isolated perfused rat brain.
    Krieglstein J; Rieger H; Schütz H
    Biochem Pharmacol; 1980 Jan; 29(1):63-7. PubMed ID: 7362626
    [No Abstract]   [Full Text] [Related]  

  • 74. Effect of 3,4-dimethoxyphenylethylamine injections on the concentration of catecholamines in the rat brain.
    Barbeau A; Singh P; Gaudreau P; Joubert M
    Rev Can Biol; 1965 Sep; 24(3):229-32. PubMed ID: 5892610
    [No Abstract]   [Full Text] [Related]  

  • 75. Inhibitory potency of various peptides on enkephalinase activity from mouse striatum.
    Fournie-Zaluski MC; Perdrisot R; Gacel G; Swerts JP; Roques BP; Schwartz JC
    Biochem Biophys Res Commun; 1979 Nov; 91(1):130-5. PubMed ID: 518615
    [No Abstract]   [Full Text] [Related]  

  • 76. [On dopamine (hydroxytyramine) metabolism in the rat brain].
    HOLZER G; HORNYKIEWICZ O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1959; 237():27-33. PubMed ID: 14402902
    [No Abstract]   [Full Text] [Related]  

  • 77. Distribution of a catecholamine-binding mechanism in rat brain.
    Ishii T; Friede RL
    Histochemie; 1967; 9(2):126-35. PubMed ID: 5586448
    [No Abstract]   [Full Text] [Related]  

  • 78. Similarities and differences between D-ALA2 MET5 enkephalin amide and morphine in the induction of tolerance to their effects on catalepsy and on dopamine metabolism in the rat brain.
    De Simoni MG; Guardabasso V; Misterek K; Algeri S
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Nov; 321(2):105-11. PubMed ID: 6891440
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enkephalin, morphine, and naloxone in tardive dyskinesia.
    Bjørndal N; Casey DE; Gerlach J
    Psychopharmacology (Berl); 1980; 69(2):133-6. PubMed ID: 6779305
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.
    Daugé V; Rossignol P; Roques BP
    Psychopharmacology (Berl); 1989; 99(2):168-75. PubMed ID: 2572028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.